Top Abstract Purchase Related
Home
>
Node
>
Subnode

Comparison of withdrawal of typical and atypical antipsychotic drugs: a case study

Alphs, L.D.; Lee, H.S.

Journal of Clinical Psychiatry 52(8): 346-348

1991

ISSN/ISBN: 0160-6689
PMID: 1869497
Document Number: 378009
Haloperidol and clozapine were rapidly withdrawn from a schizophrenic patient on separate occasions several months apart. Mental status changes and fluctuations in involuntary movements were carefully observed under both conditions. Although little change in either mental status or involuntary movements was observed within the 3 weeks following the withdrawal of haloperidol, marked deterioration in mental status and involuntary movements occurred within 1 week of withdrawal of clozapine. Implications of this differential response to withdrawal of antipsychotic medications are discussed.

Document emailed within 1 workday
Secure & encrypted payments

Shoshina, I.I.; Shelepin, I.E.; Semenova, N.B. 2014: The frequency-contrast sensitivity of visual stimulus perception in patients with schizophrenia with the therapy of atypical and typical antipsychotic drugs Fiziologiia Cheloveka 40(1): 43-48
Srisurapanont, M.; Maneeton, N. 1999: Comparison of the efficacy and acceptability of atypical antipsychotic drugs: a meta-analysis of randomized, placebo-controlled trials Journal of the Medical Association of Thailand 82(4): 341-346
Roth, B.L.; Ciaranello, R.D.; Meltzer, H.Y. 1992: Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors Journal of Pharmacology and Experimental Therapeutics 260(3): 1361-1365
Roth, B.L.; Craigo, S.C.; Choudhary, M.S.; Uluer, A.; Monsma, F.J.; Shen, Y.; Meltzer, H.Y.; Sibley, D.R. 1994: Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors Journal of Pharmacology and Experimental Therapeutics 268(3): 1403-1410
Dumortier, G.; Cabaret, W.; Stamatiadis, L.; Saba, G.; Benadhira, R.; Rocamora, J.-F.; Aubriot-Delmas, B.; Glikman, J.; Januel, D. 2002: Hepatic tolerance of atypical antipsychotic drugs L'Encephale 28(6 Part 1): 542-551
Weiden, P.; Aquila, R.; Standard, J. 1996: Atypical antipsychotic drugs and long-term outcome in schizophrenia Journal of Clinical Psychiatry 57(Suppl): 53-60
Vohora, D. 2007: Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia Current Opinion in Investigational Drugs 8(7): 531-538
Czekalla, J.; Kollack-Walker, S.; Beasley, C.M. 2001: Cardiac safety parameters of olanzapine: comparison with other atypical and typical antipsychotics Journal of Clinical Psychiatry 62(Suppl): 35-40
Nyberg, S.; Nakashima, Y.; Nordström, A.L.; Halldin, C.; Farde, L. 1996: Positron emission tomography of in-vivo binding characteristics of atypical antipsychotic drugs. Review of D2 and 5-HT2 receptor occupancy studies and clinical response British Journal of Psychiatry. Supplement 1996(29): 40-44
Baker, R.A.; Pikalov, A.; Tran, Q-Van.; Kremenets, T.; Arani, R.B.; Doraiswamy, P.Murali. 2009: Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysis Psychopharmacology Bulletin 42(1): 11-31
Carroccio, A.; Di Prima, L.; Notarbartolo, A. 2004: Celiac disease: presentation of a typical case and an atypical case Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 19(1): 63-76; Quiz 77-8
Dufresne, R.L.; Wagner, R.L. 1988: Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia Journal of Clinical Psychiatry 49(11): 435-438
Puri, B.K.; Davey, N.J.; Zaman, R. 2003: Excitability of the motor cortex in schizophrenia following typical and atypical antipsychotics: two serial case reports International Journal of Clinical Practice 57(9): 831-833
Lecrubier, Y. 2000: Is amisulpride an 'atypical' atypical antipsychotic agent? International Clinical Psychopharmacology 15(Suppl 4): S21-S26
Arsen'eva, T.E.; Lebedeva, S.A.; Trukhachev, A.L.; Vasil'eva, E.A.; Ivanova, V.S.; Bozhko, N.V. 2010: Comparison of efficacy of tests for differentiation of typical and atypical strains of Yersinia pestis and Yersinia pseudotuberculosis Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 75-81
Akhtar, N.; Bari, A.; Nomani, K. 1984: Incidence of typical and atypical mycobacteria in pulmonary infections at Lahore--a study of 500 cases Jpma. Journal of the Pakistan Medical Association 34(4): 84-87
Hrdlicka, M.; Zedkova, I.; Blatny, M.; Urbanek, T. 2009: Weight gain associated with atypical and typical antipsychotics during treatment of adolescent schizophrenic psychoses: A retrospective study Neuro Endocrinology Letters 30(2): 256-261
Vuk, A.; Kuzman, M.Rojnic.; Baretic, M.; Osvatic, M.Matovinovic. 2017: Diabetic ketoacidosis associated with antipsychotic drugs: case reports and a review of literature Psychiatria Danubina 29(2): 121-135
Hirsch, S.R.; Link, C.G.; Goldstein, J.M.; Arvanitis, L.A. 1996: ICi 204,636: a new atypical antipsychotic drug British Journal of Psychiatry. Suppl 29: 45-56
Diurni, M.; Baranzini, F.; Costantini, C.; Poloni, N.; Vender, S.; Callegari, C. 2009: Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: preliminary study Recenti Progressi in Medicina 100(2): 103